STOK - Stoke Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$43.86
DETAILS
HIGH:
$60.00
LOW:
$35.00
MEDIAN:
$40.00
CONSENSUS:
$43.86
UPSIDE:
49.49%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 100.0% |
| EBIT Margin | -11.2% |
| EBITDA Margin | -10.2% |
| Operating Margin | -11.2% |
| Pretax Margin | -3.7% |
| Cont. Ops Margin | -3.7% |
| Net Margin | -3.7% |
| Bottom Line Margin | -3.7% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 5.28 |
| Quick Ratio | 5.28 |
| Solvency Ratio | -0.078 |
| Cash Ratio | 1.46 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-273.00
Peers avg: 37.9
|
| PEG Ratio | 2.94 |
| Forward PEG | 2.94 |
| Price/Book | 5.33 |
| Price/Sales | 10.19 |
| Price/FCF | 41.85 |
| Price/Op Cash Flow | 41.23 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0000 |
| Debt/Equity | 0.0000 |
| Debt/Capital | 0.0000 |
| Long-Term Debt/Capital | 0.0000 |
| Financial Leverage | 1.19 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.84 |
| Operating Cash Flow Ratio | 0.788 |
| Operating Cash Flow/Sales | 24.7% |
| Free Cash Flow/Operating Cash Flow | 98.5% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | 0.00 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | 0.00 |
| Operating Cash Flow Coverage | 0.00 |
| Capital Expenditure Coverage | 68.04 |
| Dividend + Capital Expenditure Coverage | 68.04 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 3.11 |
| EPS | -0.116 |
| Debt/Share | 0.0000 |
| Cash/Share | 4.81 |
| Book Value/Share | 5.95 |
| Tangible BV/Share | 5.95 |
| Equity/Share | 5.95 |
| Operating Cash Flow/Share | 0.770 |
| Capital Expenditure/Share | 0.011 |
| FCF/Share | 0.758 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.000 |
| Earnings Before Tax/EBIT | 0.334 |
| Price/Fair Value | 5.33 |
| Debt/Market Cap | 0.0000 |
| Effective Tax Rate | 0.0% |
| Enterprise Value Multiple | -95.40 |